Arcutis Biotherapeutics (ARQT) Total Assets (Quarterly): 524.43M

Arcutis Biotherapeutics, Inc. (ARQT)

27.53 -0.85 (-3.00%) USD | NASDAQ | Nov 12, 16:00

28.18 +0.65 (+2.36%) After-Hours: 07:17

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
September 30, 2026	524.43M
June 30, 2026	488.54M
March 31, 2026	460.00M
December 31, 2025	432.97M
September 30, 2025	370.98M
June 30, 2025	352.43M
March 31, 2025	344.10M
December 31, 2024	348.89M
September 30, 2024	437.35M
June 30, 2024	444.76M
March 31, 2024	478.54M
December 31, 2023	341.36M
September 30, 2023	292.96M
June 30, 2023	320.69M
March 31, 2023	379.46M
December 31, 2022	449.27M

Date	Value
September 30, 2022	508.91M
June 30, 2022	300.46M
March 31, 2022	364.11M
December 31, 2021	408.15M
September 30, 2021	387.01M
June 30, 2021	432.89M
March 31, 2021	471.42M
December 31, 2020	298.27M
September 30, 2020	198.01M
June 30, 2020	231.97M
March 31, 2020	254.39M
December 31, 2019	107.01M
September 30, 2019	28.30M
June 30, 2019	38.18M
March 31, 2019
December 31, 2018	51.10M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks